Protalix BioTherapeutics
PLX
C$1.89
Share price
-2.82%
Change (1 day)
20.37%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - Total assets
Total assets on the balance sheet as of March 2025 : C$0.10 Billion
According to Protalix BioTherapeutics 's latest financial reports the company's total assets are C$0.10 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Protalix BioTherapeutics - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | C$0.10 B | -5.93% |
| 2023-12-31 | C$0.11 B | 47.94% |
| 2022-12-31 | C$75.7 M | -19.37% |
| 2021-12-31 | C$93.88 M | 8.38% |
| 2020-12-31 | C$86.62 M | 46.11% |
| 2019-12-31 | C$59.28 M | -28.81% |
| 2018-12-31 | C$83.27 M | -8.28% |
| 2017-12-31 | C$90.79 M | -17.86% |
| 2016-12-31 | C$0.11 B | -18.07% |
| 2015-12-31 | C$0.13 B | 48.36% |
| 2014-12-31 | C$90.93 M | -24.63% |
| 2013-12-31 | C$0.12 B | 54.11% |
| 2012-12-31 | C$78.28 M | 48.56% |
| 2011-12-31 | C$52.69 M | -18.56% |
| 2010-12-31 | C$64.7 M | -37.68% |
| 2009-12-31 | C$0.10 B | 68.05% |
| 2008-12-31 | C$61.78 M | -9.11% |
| 2007-12-31 | C$67.97 M | 116.32% |
| 2006-12-31 | C$31.42 M | 273.55% |
| 2005-12-31 | C$8.41 M | 1137.34% |
| 2004-12-31 | C$0.67 M | -28.63% |
| 2003-12-31 | C$0.95 M | -31.1% |
| 2002-12-31 | C$1.38 M | -15.19% |
| 2001-12-31 | C$1.62 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amicus Therapeutics
FOLD | C$1.08 B | 968.91% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | C$5.05 B | 4,890.66% | 🇺🇸 USA |
 Pfizer PFE | C$285.36 B | 281,429.80% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | C$52.69 B | 51,888.04% | 🇮🇱 Israel |